FDA Documents of KBI Biopharma, Inc.
KBI Biopharma, Inc. is an organization that has been audited by the FDA 10 times between 2015 and 2024 across all 3 sites.
Documents
FDA EIR KBI Biopharma, Durham | January 2022
Available Now - $995
Issued on: Jan 13, 2022
Human Drug Form 483
FDA 483 KBI Biopharma, Boulder | December 2021
Available Now - $199
Issued on: Dec 3, 2021
Human Drug Form 483
FDA 483 KBI Biopharma, Boulder | March 2020
Available Now - $199
Issued on: Mar 6, 2020
Human Drug Form 483
FDA 483 KBI Biopharma, Inc., Durham | 2024
Out-of-stock
Issued on: Jun 18, 2024
Human Drugs Form 483
FDA 483 KBI Biopharma, Inc., Durham | 2020
Out-of-stock
Issued on: Sep 29, 2020
Human Drug Form 483
FDA 483 KBI Biopharma, Inc., Boulder | 2018
Out-of-stock
Issued on: Sep 12, 2018
Human Drug Form 483
FDA 483 KBI Biopharma, Inc., Boulder | 2016
Out-of-stock
Issued on: Dec 9, 2016
Human Drug Form 483
FDA Investigators(18)
- Michael Shanks, FDA Investigator
- Olumide A. Martins,
- Ayyappan Rathakrishnan,
- Kamal N. Tiwari,
- Seneca D. Toms, FDA Investigator
- Nicholas L. Hunt, FDA Investigator
- Michael A. Charles, FDA Investigator
- Viviana Matta, FDA Investigator
- Erika V. Butler, FDA Investigator
- Genoula K. Ryan, FDA Investigator
- Ralph M. Bernstein, FDA Investigator
- Jamie L. Dion, FDA Investigator
- Scott R. Nichols, FDA Investigator
- Adam R. Cooke, FDA Investigator
- Marion Michaelis, FDA Investigator
- Monica M. Commerford, FDA Investigator
- Lillie D. Witcher, FDA Investigator
- Lauryl A. Smith, FDA Investigator